Novartis AG Newsroom

Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights

BenzingaOct 31 03:12

Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy

BenzingaOct 31 02:31

USDA Says H5N1 Bird Flu Detected In Swine For The First Time In U.S. In Oregon Backyard Farm; There Is No Concern About Safety Of The Nation's Pork Supply As A Result Of This Finding On HPAI Detections In Oregon Backyard Farm

BenzingaOct 31 01:05

USDA To Begin Bulk Milk Testing For Bird Flu Nationwide Following Pressure From Industry And Veterinary Groups; New Effort Aims To Curb Rapid Spread Among Dairy Herds

BenzingaOct 31 01:03

Lilly's Q3 Earnings Miss, Mounjaro, Zepbound Disappoint, Stock Tanks

Zacks Oct 30 22:55

Novartis Is Maintained at Market Perform by BMO Capital

Dow JonesOct 30 22:16 · Ratings

Novartis Analyst Ratings

BenzingaOct 30 22:05 · Ratings

TD Cowen Maintains Novartis AG(NVS.US) With Hold Rating

Futu NewsOct 30 20:33 · Ratings

BMO Capital Maintains Novartis AG(NVS.US) With Hold Rating, Raises Target Price to $120

Futu NewsOct 30 19:31 · Ratings

Express News | Novartis AG : BMO Raises Target Price to $120 From $118

BreakingsOct 30 19:17

The total amount is approximately $17 billion! Pfizer (PFE.US), Novartis (NVS.US) and others have recently introduced which new drugs under development?

In recent years, new drug licensing cooperation has become one of the important trends in the industry. Public information shows that since October alone this year, there have been nearly 30 licensing cooperation events worldwide, involving actions by multiple international pharmaceutical companies.

Zhitong FinanceOct 30 15:27

Express News | Deutsche Bank: Lowered Novartis target price from 105 Swiss francs to 100 Swiss francs.

BreakingsOct 30 15:26

Novartis' Chronic Myeloid Leukemia Drug Wins Accelerated US FDA Approval

MT NewswiresOct 30 12:16

Novartis Stock Dives on $800 Million Write-Down -- WSJ

WSJOct 30 02:15

Sector Update: Health Care Stocks Ease Tuesday Afternoon

MT NewswiresOct 30 01:57

FDA Grants Accelerated Approval To Novartis's Asciminib For Philadelphia Chromosome-Positive Chronic Myeloid Leukemia; Clinical Trial Shows 25% Major Molecular Response Rate At 24 Weeks Compared To 13% For Bosutinib

BenzingaOct 30 01:35

Novartis on Pace for Largest Percent Decrease Since March 2021 -- Data Talk

Dow JonesOct 30 01:25

Swiss Equities Tumble; Novartis Falls Despite Q3 Growth

MT NewswiresOct 30 01:14

Novartis AG (NVS) Q3 2024 Earnings Call Transcript Summary

Futu NewsOct 30 00:24 · Conference Call

Top Midday Stories: McDonald's Beats Estimates on Q3 EPS, Revenue, Misses on Same-Store Sales; Ford Lowers EBIT Guidance

MT NewswiresOct 30 00:13